Abstract
Hepatic fibrosis is a chronic disease that results from hepatitis C infection. The tests used to screen for chronic liver disease are known as serum biochemical liver tests (LTs) (alanine aminotransferase, aspartate aminotransferase, and gamma glutamyl transferase). Objectives: To determine the prevalence and etiologies of abnormal LTs in the population of Lahore, Pakistan. To determine whether there is any correlation of HCV infection and viral load to the clinical parameters such as ALT, AST, ALP, bilirubin, patient's age and gender. Methods: Liver function tests (ALT, AST, and Bilirubin) were carried out using standard kits and a regular chemical analyzer in a photometric manner. Results: In our research, we gathered information from 80 patients, out of whom 27 women and 53 men. HCV was more common in the adult population aged 30 years or older and in men than in women. These individuals had elevated levels of several biochemical markers as ALT, AST, and ALP. Conclusions: Based on the results of this research and our investigation, we saw instances of viral hepatitis being diagnosed in asymptomatic patients with abnormal LFTs. The findings of the present investigation showed that men and patients under the age of 30 in Lahore had a significant frequency of abnormal LTs. Test results reveal biochemical markers at particularly elevated levels. Implementing initiatives to lessen the potential burden of chronic liver disease may benefit from knowing the estimated prevalence and etiologies of aberrant LTs (CLD).
Publisher
CrossLinks International Publishers
Reference21 articles.
1. 1. Gasiorowicz M, Hurie M, Russell A, Hoxie N, Vergeront J. Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin. Wisconsin Medical Journal-MADISON. 2006 Jan; 105(1): 34-39.
2. 2. Alter HJ and Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Seminars in liver disease. 2000; 20(01): 0017-0036. doi: 10.1055/s-2000-9505.
3. 3. Sy T and Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. International Journal of Medical Sciences. 2006 Apr; 3(2): 41-6. doi: 10.7150/ijms.3.41.
4. 4. Lok ASF and McMahon BJ. Chronic hepatitis B. Hepatology. 2007 Feb; 45(2):507-39. doi: 10.1002/hep.21513.
5. 5. Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. The Lancet. 2008 Jul; 372(9635): 321-32. doi: 10.1016/S0140-6736(08)61116-2.